News

Synendos selected for the Innousuisse start-up core coaching program

Synendos received a co-fund from the European Union as part of the SME Instrument programme (EUR 50’000)

Synendos Therapeutics gets an Innobooster grant from Gebert Rüf Stiftung (CHF 150'000)

Synendos Therapeutics won Venture Kick Stage II (CHF 40’000)

Synendos Therapeutics selected among top10 finalist of >>venture>> competition

Synendos Therapeutics is among the finalists at the perfect pitch competition held at the BioTrinity London conference.